New, sophisticated drugs did not move the needle on hearts attacks, strokes: what this teaches us
The Hindu — Health · 19 Sep 2026
We couldn't retrieve the full article from The Hindu — Health, so this is the available summary.
Drugs built against specific biomarkers hsCRP and Lp(a) both failed to reduce the number of heart attacks and strokes, in recent clinical trials. Cardiovascular medicine teaches us again and again that the interventions with the best evidence are still the boring ones: eat well, move, don’t smoke, stay lean
Related articles
India · The Hindu — Health · 1 day agoWhose sight matters? How gender shapes access to eye care in India
Across their lifespans, from childhood to old age, women face disadvantages in access to eye health and care. For many, treatment depends on how…
Read full article
India · The Hindu — Health · 1 day agoHow infant deaths in Keralam’s Attappady expose a deep-rooted health, social crisis
12 infants, including 10 tribals, have died in Attappady this year, sparking a political row as the State government orders an expert probe. Tribal…
Read full article
India · The Hindu — Health · 2 days agoIndia orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to…
Read full article